152 related articles for article (PubMed ID: 33965627)
1. Orosomucoid can predict baseline peritoneal transport characteristics in peritoneal dialysis patients and reduce peritoneal proteins loss.
Bao M; Sun Z; Yang X; Ji J; Zhang L; Xiang B; Yan G; Ding X; Zou J; Yu X
J Proteomics; 2021 Jun; 242():104260. PubMed ID: 33965627
[TBL] [Abstract][Full Text] [Related]
2. Impact of combination therapy with peritoneal dialysis and hemodialysis on peritoneal function.
Moriishi M; Kawanishi H; Tsuchiya S
Adv Perit Dial; 2010; 26():67-70. PubMed ID: 21348383
[TBL] [Abstract][Full Text] [Related]
3. Peritoneal transport status influence on atherosclerosis/inflammation in CAPD patients.
Sezer S; Tutal E; Arat Z; Akçay A; Celik H; Ozdemir FN; Haberal M
J Ren Nutr; 2005 Oct; 15(4):427-34. PubMed ID: 16198934
[TBL] [Abstract][Full Text] [Related]
4. Influence of peritoneal transport rate, inflammation, and fluid removal on nutritional status and clinical outcome in prevalent peritoneal dialysis patients.
Chung SH; Heimbürger O; Stenvinkel P; Wang T; Lindholm B
Perit Dial Int; 2003; 23(2):174-83. PubMed ID: 12713086
[TBL] [Abstract][Full Text] [Related]
5. Proteomic analysis of peritoneal dialysate fluid in patients with different types of peritoneal membranes.
Sritippayawan S; Chiangjong W; Semangoen T; Aiyasanon N; Jaetanawanitch P; Sinchaikul S; Chen ST; Vasuvattakul S; Thongboonkerd V
J Proteome Res; 2007 Nov; 6(11):4356-62. PubMed ID: 17924681
[TBL] [Abstract][Full Text] [Related]
6. Proteomic profiling of peritoneal dialysis effluent-derived extracellular vesicles: a longitudinal study.
Carreras-Planella L; Soler-Majoral J; Rubio-Esteve C; Morón-Font M; Franquesa M; Bonal J; Troya-Saborido MI; Borràs FE
J Nephrol; 2019 Dec; 32(6):1021-1031. PubMed ID: 31617158
[TBL] [Abstract][Full Text] [Related]
7. Proteomic Research in Peritoneal Dialysis.
Bonomini M; Borras FE; Troya-Saborido M; Carreras-Planella L; Di Liberato L; Arduini A
Int J Mol Sci; 2020 Jul; 21(15):. PubMed ID: 32752018
[TBL] [Abstract][Full Text] [Related]
8. Association between inflammation and changes in residual renal function and peritoneal transport rate during the first year of dialysis.
Chung SH; Heimbürger O; Stenvinkel P; Bergström J; Lindholm B
Nephrol Dial Transplant; 2001 Nov; 16(11):2240-5. PubMed ID: 11682675
[TBL] [Abstract][Full Text] [Related]
9. High peritoneal permeability is not associated with higher mortality or technique failure in patients on automated peritoneal dialysis.
Yang X; Fang W; Bargman JM; Oreopoulos DG
Perit Dial Int; 2008; 28(1):82-92. PubMed ID: 18178952
[TBL] [Abstract][Full Text] [Related]
10. Glycoprotein 96 in Peritoneal Dialysis Effluent-Derived Extracellular Vesicles: A Tool for Evaluating Peritoneal Transport Properties and Inflammatory Status.
Fang J; Tong Y; Ji O; Wei S; Chen Z; Song A; Li P; Zhang Y; Zhang H; Ruan H; Ding F; Liu Y
Front Immunol; 2022; 13():824278. PubMed ID: 35222405
[TBL] [Abstract][Full Text] [Related]
11. Proteomic analysis in peritoneal dialysis patients with different peritoneal transport characteristics.
Wen Q; Zhang L; Mao HP; Tang XQ; Rong R; Fan JJ; Yu XQ
Biochem Biophys Res Commun; 2013 Aug; 438(3):473-8. PubMed ID: 23916703
[TBL] [Abstract][Full Text] [Related]
12. A prospective, proteomics study identified potential biomarkers of encapsulating peritoneal sclerosis in peritoneal effluent.
Zavvos V; Buxton AT; Evans C; Lambie M; Davies SJ; Topley N; Wilkie M; Summers A; Brenchley P; Goumenos DS; Johnson TS
Kidney Int; 2017 Oct; 92(4):988-1002. PubMed ID: 28673451
[TBL] [Abstract][Full Text] [Related]
13. Peritoneal inflammation and fibrosis in C-reactive protein transgenic mice undergoing peritoneal dialysis solution treatment.
Poon PY; Lan HY; Kwan BC; Huang XR; Chow KM; Szeto CC; Li PK
Nephrology (Carlton); 2017 Feb; 22(2):125-132. PubMed ID: 26857687
[TBL] [Abstract][Full Text] [Related]
14. [The clinical significance of peritoneal transport in children during first year of peritoneal dialysis].
Roszkowska-Blaim M; Skrzypczyk P
Pol Merkur Lekarski; 2014 Oct; 37(220):212-6. PubMed ID: 25518575
[TBL] [Abstract][Full Text] [Related]
15. Association between residual renal function, inflammation and patient survival in new peritoneal dialysis patients.
Chung SH; Heimbürger O; Stenvinkel P; Qureshi AR; Lindholm B
Nephrol Dial Transplant; 2003 Mar; 18(3):590-7. PubMed ID: 12584284
[TBL] [Abstract][Full Text] [Related]
16. Relationship of peritoneal transport rate and dialysis adequacy with inflammation in peritoneal dialysis patients.
Fein PA; Fazil I; Rafiq MA; Schloth T; Matza B; Chattopadhyay J; Avram MM
Adv Perit Dial; 2006; 22():2-6. PubMed ID: 16983929
[TBL] [Abstract][Full Text] [Related]
17. Impact of peritoneal transport characteristics on cardiac function in paediatric peritoneal dialysis patients: a Turkish Pediatric Peritoneal Dialysis Study Group (TUPEPD) report.
Bakkaloglu SA; Saygili A; Sever L; Aksu N; Noyan A; Akman S; Ekim M; Doganay B; Yildiz N; Akalin F; Caliskan S; Kara OD; Duzova A; Soylu A; Atalay S
Nephrol Dial Transplant; 2010 Jul; 25(7):2296-303. PubMed ID: 20139065
[TBL] [Abstract][Full Text] [Related]
18. Evaluation of peritoneal transport properties at onset of peritoneal dialysis and longitudinal follow-up.
Clerbaux G; Francart J; Wallemacq P; Robert A; Goffin E
Nephrol Dial Transplant; 2006 Apr; 21(4):1032-9. PubMed ID: 16364990
[TBL] [Abstract][Full Text] [Related]
19. [Association of lipid metabolism disorder with peritoneum transport ability and mortality in peritoneal dialysis patients].
Fang YH; Jiang LP; Zhou ZJ; Wang HY; Xu H; Li XM; Chen LM; Li XW
Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2013 Jun; 35(3):327-31. PubMed ID: 23827073
[TBL] [Abstract][Full Text] [Related]
20. Downregulation of orosomucoid 2 acts as a prognostic factor associated with cancer-promoting pathways in liver cancer.
Zhu HZ; Zhou WJ; Wan YF; Ge K; Lu J; Jia CK
World J Gastroenterol; 2020 Feb; 26(8):804-817. PubMed ID: 32148378
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
